Investigating Doxorubicin’s mechanism of action in cervical cancer: a convergence of transcriptomic and metabolomic perspectives
Introduction: Cervical cancer remains a significant global health burden, and Doxorubicin is a crucial therapeutic agent against this disease. However, the precise molecular mechanisms responsible for its therapeutic effects are not fully understood.Methods: In this study, we employed a multi-omics...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2023-08-01
|
| Series: | Frontiers in Genetics |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fgene.2023.1234263/full |
| _version_ | 1797735931126480896 |
|---|---|
| author | Zhuo Huang Zhuo Huang Zhuo Huang Huining Jing Huining Jing Huining Jing Juanjuan Lv Juanjuan Lv Yan Chen Yan Chen YuanQiong Huang Shuwen Sun Shuwen Sun |
| author_facet | Zhuo Huang Zhuo Huang Zhuo Huang Huining Jing Huining Jing Huining Jing Juanjuan Lv Juanjuan Lv Yan Chen Yan Chen YuanQiong Huang Shuwen Sun Shuwen Sun |
| author_sort | Zhuo Huang |
| collection | DOAJ |
| description | Introduction: Cervical cancer remains a significant global health burden, and Doxorubicin is a crucial therapeutic agent against this disease. However, the precise molecular mechanisms responsible for its therapeutic effects are not fully understood.Methods: In this study, we employed a multi-omics approach that combined transcriptomic and metabolomic analyses with cellular and in vivo experiments. The goal was to comprehensively investigate the molecular landscape associated with Doxorubicin treatment in cervical cancer.Results: Our unbiased differential gene expression analysis revealed distinct alterations in gene expression patterns following Doxorubicin treatment. Notably, the ANKRD18B gene exhibited a prominent role in the response to Doxorubicin. Simultaneously, our metabolomic analysis demonstrated significant perturbations in metabolite profiles, with a particular focus on L-Ornithine. The correlation between ANKRD18B gene expression and L-Ornithine levels indicated a tightly controlled gene-metabolite network. These results were further confirmed through rigorous cellular and in vivo experiments, which showed reductions in subcutaneous tumor size and significant changes in ANKRD18B, L-Ornithine, and Doxorubicin concentration.Discussion: The findings of this study underscore the intricate interplay between transcriptomic and metabolomic changes in response to Doxorubicin treatment. These insights could have implications for the development of more effective therapeutic strategies for cervical cancer. The identification of ANKRD18B and L-Ornithine as key components in this process lays the groundwork for future research aiming to unravel the complex molecular networks that underlie Doxorubicin’s therapeutic mechanism. While this study provides a solid foundation, it also highlights the necessity for further investigation to fully grasp these interactions and their potential implications for cervical cancer treatment. |
| first_indexed | 2024-03-12T13:06:15Z |
| format | Article |
| id | doaj.art-45f7ea29f62e4d198b25633457d4f188 |
| institution | Directory Open Access Journal |
| issn | 1664-8021 |
| language | English |
| last_indexed | 2024-03-12T13:06:15Z |
| publishDate | 2023-08-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Genetics |
| spelling | doaj.art-45f7ea29f62e4d198b25633457d4f1882023-08-28T14:59:36ZengFrontiers Media S.A.Frontiers in Genetics1664-80212023-08-011410.3389/fgene.2023.12342631234263Investigating Doxorubicin’s mechanism of action in cervical cancer: a convergence of transcriptomic and metabolomic perspectivesZhuo Huang0Zhuo Huang1Zhuo Huang2Huining Jing3Huining Jing4Huining Jing5Juanjuan Lv6Juanjuan Lv7Yan Chen8Yan Chen9YuanQiong Huang10Shuwen Sun11Shuwen Sun12Department of Pediatrics, West China Second University Hospital, Sichuan University, Chengdu, ChinaKey Laboratory of Birth Defects and Related Diseases of Women and Children, Ministry of Education, West China Second University Hospital, Sichuan University, Chengdu, ChinaDepartment of Medical Genetics, West China Second University Hospital, Sichuan University, Chengdu, ChinaKey Laboratory of Birth Defects and Related Diseases of Women and Children, Ministry of Education, West China Second University Hospital, Sichuan University, Chengdu, ChinaDepartment of Medical Genetics, West China Second University Hospital, Sichuan University, Chengdu, ChinaDepartment of Obstetrics and Gynecology, West China Second University Hospital, Sichuan University, Chengdu, ChinaDepartment of Pediatrics, West China Second University Hospital, Sichuan University, Chengdu, ChinaKey Laboratory of Birth Defects and Related Diseases of Women and Children, Ministry of Education, West China Second University Hospital, Sichuan University, Chengdu, ChinaDepartment of Pediatrics, West China Second University Hospital, Sichuan University, Chengdu, ChinaKey Laboratory of Birth Defects and Related Diseases of Women and Children, Ministry of Education, West China Second University Hospital, Sichuan University, Chengdu, ChinaDepartment of Oncology, Luzhou Hospital of Traditional Chinese Medicine, Luzhou, ChinaDepartment of Pediatrics, West China Second University Hospital, Sichuan University, Chengdu, ChinaKey Laboratory of Birth Defects and Related Diseases of Women and Children, Ministry of Education, West China Second University Hospital, Sichuan University, Chengdu, ChinaIntroduction: Cervical cancer remains a significant global health burden, and Doxorubicin is a crucial therapeutic agent against this disease. However, the precise molecular mechanisms responsible for its therapeutic effects are not fully understood.Methods: In this study, we employed a multi-omics approach that combined transcriptomic and metabolomic analyses with cellular and in vivo experiments. The goal was to comprehensively investigate the molecular landscape associated with Doxorubicin treatment in cervical cancer.Results: Our unbiased differential gene expression analysis revealed distinct alterations in gene expression patterns following Doxorubicin treatment. Notably, the ANKRD18B gene exhibited a prominent role in the response to Doxorubicin. Simultaneously, our metabolomic analysis demonstrated significant perturbations in metabolite profiles, with a particular focus on L-Ornithine. The correlation between ANKRD18B gene expression and L-Ornithine levels indicated a tightly controlled gene-metabolite network. These results were further confirmed through rigorous cellular and in vivo experiments, which showed reductions in subcutaneous tumor size and significant changes in ANKRD18B, L-Ornithine, and Doxorubicin concentration.Discussion: The findings of this study underscore the intricate interplay between transcriptomic and metabolomic changes in response to Doxorubicin treatment. These insights could have implications for the development of more effective therapeutic strategies for cervical cancer. The identification of ANKRD18B and L-Ornithine as key components in this process lays the groundwork for future research aiming to unravel the complex molecular networks that underlie Doxorubicin’s therapeutic mechanism. While this study provides a solid foundation, it also highlights the necessity for further investigation to fully grasp these interactions and their potential implications for cervical cancer treatment.https://www.frontiersin.org/articles/10.3389/fgene.2023.1234263/fullcervical cancerDoxorubicintranscriptomicsmetabolomicsANKRD18BL-Ornithine |
| spellingShingle | Zhuo Huang Zhuo Huang Zhuo Huang Huining Jing Huining Jing Huining Jing Juanjuan Lv Juanjuan Lv Yan Chen Yan Chen YuanQiong Huang Shuwen Sun Shuwen Sun Investigating Doxorubicin’s mechanism of action in cervical cancer: a convergence of transcriptomic and metabolomic perspectives Frontiers in Genetics cervical cancer Doxorubicin transcriptomics metabolomics ANKRD18B L-Ornithine |
| title | Investigating Doxorubicin’s mechanism of action in cervical cancer: a convergence of transcriptomic and metabolomic perspectives |
| title_full | Investigating Doxorubicin’s mechanism of action in cervical cancer: a convergence of transcriptomic and metabolomic perspectives |
| title_fullStr | Investigating Doxorubicin’s mechanism of action in cervical cancer: a convergence of transcriptomic and metabolomic perspectives |
| title_full_unstemmed | Investigating Doxorubicin’s mechanism of action in cervical cancer: a convergence of transcriptomic and metabolomic perspectives |
| title_short | Investigating Doxorubicin’s mechanism of action in cervical cancer: a convergence of transcriptomic and metabolomic perspectives |
| title_sort | investigating doxorubicin s mechanism of action in cervical cancer a convergence of transcriptomic and metabolomic perspectives |
| topic | cervical cancer Doxorubicin transcriptomics metabolomics ANKRD18B L-Ornithine |
| url | https://www.frontiersin.org/articles/10.3389/fgene.2023.1234263/full |
| work_keys_str_mv | AT zhuohuang investigatingdoxorubicinsmechanismofactionincervicalcanceraconvergenceoftranscriptomicandmetabolomicperspectives AT zhuohuang investigatingdoxorubicinsmechanismofactionincervicalcanceraconvergenceoftranscriptomicandmetabolomicperspectives AT zhuohuang investigatingdoxorubicinsmechanismofactionincervicalcanceraconvergenceoftranscriptomicandmetabolomicperspectives AT huiningjing investigatingdoxorubicinsmechanismofactionincervicalcanceraconvergenceoftranscriptomicandmetabolomicperspectives AT huiningjing investigatingdoxorubicinsmechanismofactionincervicalcanceraconvergenceoftranscriptomicandmetabolomicperspectives AT huiningjing investigatingdoxorubicinsmechanismofactionincervicalcanceraconvergenceoftranscriptomicandmetabolomicperspectives AT juanjuanlv investigatingdoxorubicinsmechanismofactionincervicalcanceraconvergenceoftranscriptomicandmetabolomicperspectives AT juanjuanlv investigatingdoxorubicinsmechanismofactionincervicalcanceraconvergenceoftranscriptomicandmetabolomicperspectives AT yanchen investigatingdoxorubicinsmechanismofactionincervicalcanceraconvergenceoftranscriptomicandmetabolomicperspectives AT yanchen investigatingdoxorubicinsmechanismofactionincervicalcanceraconvergenceoftranscriptomicandmetabolomicperspectives AT yuanqionghuang investigatingdoxorubicinsmechanismofactionincervicalcanceraconvergenceoftranscriptomicandmetabolomicperspectives AT shuwensun investigatingdoxorubicinsmechanismofactionincervicalcanceraconvergenceoftranscriptomicandmetabolomicperspectives AT shuwensun investigatingdoxorubicinsmechanismofactionincervicalcanceraconvergenceoftranscriptomicandmetabolomicperspectives |